MarketInOut Stock Screener Log In | Sign Up

GlaxoSmithKline Pharmaceuticals Ltd

Healthcare • Drug Manufacturers - General • Quote as of 10/28/2026 15:57
GlaxoSmithKline Pharmaceuticals Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
Market Capitalization409,285 mln
Float41.29 mln
Earnings Date11/03/2026

EPS

63.05
Exceptional

P / E

39.62
Overvalued

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.6
Likely reliable

1-Year Forecast

3,097.25
Attractive

Relative Strength

70 / 100
Outperforming

Business Description

GlaxoSmithKline Pharmaceuticals Limited, a subsidiary of GSK plc, makes and sells a wide range of medical products in India and around the world. Its portfolio includes vaccines that protect infants and adults against serious infections such as influenza, hepatitis, meningitis, and chickenpox. The company also offers treatments for respiratory conditions like severe asthma and chronic obstructive pulmonary disease, alongside everyday medicines covering bacterial infections, skin conditions, pain relief, and thyroid disorders.

Key Fundamentals

EPS63.05
P/E39.62
ROE54.07
RPS233
ROIC69.83
ROA26.43
Interest Cover396
EBITDA, mln15,195
EV / EBITDA29.27
EV / EBIT30.61
Revenue, mln39,549
EV / Revenue11.24

Quote Details

Last 2,498.00
Change 25.6 (1.04%)
Open 2,469.90
Volume 24,842
Turnover 62,055,316
Average Volume 66,306

Financial Ratios

Pre-Tax Profit Margin37
Current Ratio2.03
Price / Book20.71
Price / Tangible Book20.78
Price / Cash Flow223
Price / Free Cash Flow48.71
Debt / Equity0.02
Price / Sales11.88
PEG Ratio2.18

Financial Strength

Altman Z-Score16.67
Piotroski F-Score 5 / 9
Beneish M-Score-2.6
Price to Intrinsic Value3.88
Price to Lynch Fair Value2.43
Price to Graham Number6.44
1-Year Target Price3,097.25
Shiller PE Ratio53.50

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 1.36% 77 / 100   
1 Month -11.28% 31 / 100   
2 Months -0.34% 70 / 100   
6 Months 4.99% 69 / 100   
1 Year -6.63% 62 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog